Nalaganje...

Molecular response of gastrointestinal stromal tumour after treatment with tyrosine kinase inhibitor imatinib mesylate

Bleeding from the tumour site is not uncommon during the treatment of gastrointestinal stromal tumours with imatinib mesylate. It might represent an early reaction of highly vascularised tumour tissue to receptor blockade. Although often requiring emergency surgery, this is not necessarily a deleter...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Reichardt, P, Schneider, U, Stroszczynski, C, Pink, D, Hohenberger, P
Format: Artigo
Jezik:Inglês
Izdano: Copyright 2004 Journal of Clinical Pathology 2004
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1770203/
https://ncbi.nlm.nih.gov/pubmed/14747457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jcp.2004.11379
Oznake: Označite
Brez oznak, prvi označite!